Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases

NCT05903937 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER_GOV

Sponsor class

Conditions

Uveal Melanoma
Metastatic Cutaneous Melanoma

Interventions

DRUG: Autologous Tumor Infiltrating Lymphocytes
DRUG: Melphalan
DRUG: Interleukin-2

Sponsor

Vastra Gotaland Region